Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
The Indian Institute of Science (IISc) and the Indian Navy have signed an MoU to collaborate on aviation research and development, and to ramp up self-reliance efforts for the Navy in line with the goals of 'Atmanirbhar Bharat'.
EXAMIANS